XML 80 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity for the nine months ended September 30, 2014:

 

     Number of
Options
    Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual Term
(in years)
     Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2013

     6,614,534      $ 22.12         

Granted

     851,213      $ 75.57         

Exercised

     (1,593,563   $ 13.87         

Forfeited

     (427,701   $ 45.89         

Expired

     (243   $ 48.18         
  

 

 

         

Outstanding at September 30, 2014

     5,444,240      $ 31.02         6.49       $ 369.4   
  

 

 

         

Vested and exercisable at September 30, 2014

     3,613,023      $ 18.42         5.43       $ 290.7   
  

 

 

         

 

(1)  The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $98.87 of the Company’s common stock on September 30, 2014. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on September 30, 2014. The amounts are presented in millions.
Summary of Restricted Stock Units

Restricted Stock Units

The following table summarizes restricted stock unit activity for the nine months ended September 30, 2014:

 

     Number of
Shares
    Weighted-
Average
Grant-Date
Fair Value
 

Unvested at December 31, 2013

     311,347      $ 52.57   

Granted

     345,034      $ 79.85   

Vested

     (37,952   $ 53.11   

Forfeited

     (74,254   $ 62.73   
  

 

 

   

Unvested at September 30, 2014

     544,175      $ 68.64   
  

 

 

   
Summary of Stock Appreciation Rights Activity

The following table summarizes stock appreciation rights activity for the nine months ended September 30, 2014:

 

     Number of
Rights
    Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual Term
(in years)
     Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2013

     806,116      $ 23.98         

Granted

     —       $ —          

Exercised

     (58,850   $ 23.71        

Forfeited

     (10,384   $ 24.40        
  

 

 

         

Outstanding at September 30, 2014

     736,882      $ 23.99         7.03       $ 55.2   
  

 

 

         

Vested and exercisable at September 30, 2014

     494,136      $ 24.01         6.94       $ 37.0   
  

 

 

         

 

(1)  The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $98.87 of the Company’s common stock on September 30, 2014. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on September 30, 2014. The amounts are presented in millions.
Schedule of Black-Scholes Assumptions Used for Stock Options

Black-Scholes assumptions used to estimate the fair value of stock options granted during the periods were as follows:

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2014     2013     2014     2013  

Risk-free interest rate

     1.56-1.79     1.45     1.56-1.79     0.73-1.55

Estimated term (in years)

     5.06        5.25        5.06-5.50        5.24-5.50   

Estimated volatility

     63     68     60-64     68-75

Estimated dividend yield

     —         —         —         —    
Schedule of Black-Scholes Assumptions Used to Estimate Fair Value of Shares Issued under ESPP

The Black-Scholes assumptions used to estimate the fair value of shares issued under the ESPP on the commencement date of the offering period were as follows. No offering periods commenced during the third quarter of 2014.

 

     Nine Months Ended
September 30, 2014
 

Risk-free interest rate

     0.06

Estimated term (in years)

     0.50   

Estimated volatility

     53

Estimated dividend yield

     —    
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense was as follows:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2014      2013      2014      2013  

Stock-based compensation expense recognized as:

           

R&D expense

   $ 4,611       $ 3,765       $ 13,236       $ 11,202   

SG&A expense

     7,346         5,436         19,563         14,426   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 11,957       $ 9,201       $ 32,799       $ 25,628